Concepedia

J I Johnson

JI

Statistics

Publications

6

Citations

2.6K

H-Index

6

Active since

1993

Affiliations

National Cancer Institute(Current)

J I Johnson is an author at National Cancer Institute specializing in cancer pharmacology, pharmacology, and medicine.

Publications per year

1993–2001

6

Publications

6

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Julian Adams, Vito J. Palombella, Edward A. Sausville et al. · PubMed · 1999 · 1.5K citations

, , +14

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

J I Johnson, Shannon Decker, Daniel Zaharevitz et al. · British Journal of Cancer · 2001 · 858 citations · Full text

, , +14

Inhibition of CDKs as a Therapeutic Modality

Edward A. Sausville, J I Johnson, Michael C. Alley et al. · Annals of the New York Academy of Sciences · 2000 · 81 citations

, , +17

VRCTC-310 — A novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity

Robert A. Newman, Juan C. Vidal, Luis J. Viskatis et al. · Investigational New Drugs · 1993 · 52 citations

, , +7

Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs.

Mark W. Kunkel, David Kirkpatrick, J I Johnson et al. · PubMed · 1997 · 51 citations

, , +14

1–5 of 6